Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14
Genetic Variants of the MIF Gene and Susceptibility of Rectal Cancer
Authors Chuo D, Lin D, Yin M, Chen Y
Received 18 September 2020
Accepted for publication 5 December 2020
Published 12 January 2021 Volume 2021:14 Pages 55—60
DOI https://doi.org/10.2147/PGPM.S282653
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Martin Bluth
Dongyu Chuo, Dapeng Lin, Mingdi Yin, Yuze Chen
Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province 110042, People’s Republic of China
Correspondence: Yuze Chen
Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No. 44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning Province 110042, People’s Republic of China
Tel/Fax +86-24-31916243
Email chen_yuze@aliyun.com
Background: Rectal cancer (RC) has been documented to be a highly invasive malignant neoplasm worldwide. Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine involved in cell-mediated immunity, immunoregulation, inflammation. In vitro and in vivo studies have identified that MIF was involved in the carcinogenesis and progression of RC.
Patients and Methods: This case–control study evaluated associations of genetic variants of the MIF gene and serum level of MIF with susceptibility of RC.
Results: We found MIF level was associated with an increased risk of RC (OR for per unit: 1.38, 95% CI:1.32– 1.44; P < 0.001). Both MIF rs2012133 (OR = 1.30; 95% CIs = 1.08– 1.58; P = 0.007) and rs755622 (OR = 1.45; 95% CIs = 1.15– 1.82; P = 0.002) were significantly associated with increased risk of RC. Besides, we also found MIF rs5844572 was significantly associated with increased susceptibility of RC, with OR for per CATT repeat of 1.28 (95% CIs: 1.16– 1.41; P < 0.001). Further, we found all three variants of the MIF gene, rs5844572, rs2012133 and rs755622, could increase serum level of MIF.
Conclusion: This study suggests that MIF plays an important role in the carcinogenesis of RC and could be used as a biomarker for early detection and prediction of RC.
Keywords: rectal cancer, genetic, MIF, susceptibility, case–control
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.